Citadel Advisors
BNGO icon

Citadel Advisors’s Bionano Genomics BNGO Stock Holding History

Citadel Advisors’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-956
Closed -$16.5K – 14509
2024
Q4 		$16.5K Buy
956
+178
+23% +$3.04K ﹤0.01% 13297
2024
Q3 		$21.2K Sell
778
-192
-20% -$5.97K ﹤0.01% 12733
2024
Q2 		$39.4K Sell
970
-946
-49% -$52K ﹤0.01% 12010
2024
Q1 		$128K Sell
1,916
-684
-26% -$51.1K ﹤0.01% 11018
2023
Q4 		$295K Buy
2,600
+1,714
+193% +$179K ﹤0.01% 9193
2023
Q3 		$161K Buy
886
+236
+36% +$61.8K ﹤0.01% 10246
2023
Q2 		$238K Sell
650
-543
-46% -$245K ﹤0.01% 9513
2023
Q1 		$795K Sell
1,193
-318
-21% -$282K ﹤0.01% 7295
2022
Q4 		$1.32M Buy
1,511
+348
+30% +$438K ﹤0.01% 6276
2022
Q3 		$1.28M Buy
1,163
+421
+57% +$556K ﹤0.01% 6472
2022
Q2 		$614K Sell
742
-112
-13% -$115K ﹤0.01% 8182
2022
Q1 		$1.32M Sell
854
-1,196
-58% -$1.61M ﹤0.01% 7048
2021
Q4 		$3.68M Buy
2,050
+118
+6% +$316K ﹤0.01% 4925
2021
Q3 		$6.38M Sell
1,932
-837
-30% -$2.93M ﹤0.01% 3852
2021
Q2 		$12.2M Buy
2,769
+249
+10% +$983K ﹤0.01% 2779
2021
Q1 		$12.2M Buy
+2,520
New +$14.2M ﹤0.01% 2686

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
CCM
Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return

Citadel Advisors's BNGO Position: Q1 2025 in Review

Citadel Advisors held its Bionano Genomics (BNGO) position steady in Q1 2025 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #14510.

Citadel Advisors first reported a position in BNGO in Q2 2020 and has held it in 15 quarters since. The position peaked at $20.4M in Q1 2021. 30 funds tracked by Wall St. Rank hold BNGO as of Q1 2025.

  • Citadel Advisors held 0 shares of Bionano Genomics worth $0 as of Q1 2025.
  • Citadel Advisors left its Bionano Genomics share count unchanged in Q1 2025.
  • Bionano Genomics made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2025, its #14510 holding.
  • Citadel Advisors first reported a position in Bionano Genomics in Q2 2020 and has held it in 15 quarters since.
  • Citadel Advisors's Bionano Genomics position peaked at $20.4M in Q1 2021.
  • 30 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2025.

Based on Citadel Advisors's 13F filing for Q1 2025, filed 15 May 2025.